BMO Capital Reiterates Market Perform Rating, $263 Price Target on Amgen (AMGN) Following Q1 Report, "Still See Pricing Headwinds Impacting Core Franchises"
Tweet Send to a Friend
BMO Capital analyst Evan David Seigerman reiterated a Market Perform rating and $263.00 price target on Amgen (NASDAQ: AMGN) following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
